TradingView
RocketTickers
Jul 1, 2020 4:14 PM

FDA Approves BAVENCIO as First-Line Maintenance Treatment for Pa Long

NYSE:PFE15
Pfizer, Inc.NYSE

Description

⋅
PFE: Pfizer Inc.
2020-06-30 19:30:00
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Beyond Technical Analysis
More